| Ranbaxy gets USFDA nod for Loperamide |
| Our Web Bureau / Mumbai September 11, 2006 |
| Ranbaxy Laboratories has received approval from the US Food and Drug Administration (USFDA) to manufacture and market Loperamide Hydrochloride and Simethicone Tablets, 2 mg/125 mg. According to a release issued by Ranbaxy to the BSE today, the Office of Generic Drugs, USFDA, has determined the company's Loperamide Hydrochloride and Simethicone Tablets to be bioequivalent to the reference listed drug (RLD) Imodium |
